Compare Crocs, Inc. (CROX) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crocs, Inc. vs Novartis AG — how do they compare? Crocs, Inc. trades at $131.61 (market cap $6.31B), while Novartis AG trades at $152.33 (market cap $295.37B). The key difference: Novartis AG is far larger — about 46.8× Crocs, Inc.'s market cap, and Novartis AG pays a 3.07% dividend while Crocs, Inc. pays none. Which is the better fit depends on your goals.
| CROX | NVS | |
|---|---|---|
Market Cap | $6.31B | $295.37B |
Sector | Consumer Staples | Health |
52-Week High | $141.19 | $168.62 |
52-Week Low | $73.39 | $119.31 |
Enterprise Value | $7.83B | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crocs, Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
